platinum has been researched along with Hearing Loss in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 1 (6.25) | 29.6817 |
2010's | 7 (43.75) | 24.3611 |
2020's | 7 (43.75) | 2.80 |
Authors | Studies |
---|---|
Cardonick, EH; Finch, LE | 1 |
Brigato, F; De Corso, E; Fetoni, AR; Galli, J; Lucidi, D; Ruggiero, A; Scarano, E; Sergi, B | 1 |
Am Zehnhoff-Dinnesen, A; Ansari, M; Kompis, M; Kuehni, CE; Mader, L; Parfitt, R; Sláma, T; Strebel, S; von der Weid, NX; Waespe, N; Weiss, A | 1 |
Chadha, S; Dillard, LK; Fullerton, AM; Lopez-Perez, L; Martinez, RX; McMahon, CM | 1 |
Abrams, G; Alfaro, E; Cheung, S; Conley, Y; Cooper, B; Henderson-Sabes, J; Levine, J; Mastick, J; Miaskowski, C; Paul, S; Quinn, M; Snowberg, K; Wallhagen, M | 1 |
Ahmed, R; Attia, M; Hanna, D; Kamal, NM; Oshi, MAM; Rifky, E; Sherief, LM | 1 |
Akeroyd, MA; Baguley, DM; Pearson, SE; Phillips, OR | 1 |
Chuang, A; Cordova, M; Del Valle, Á; Waissbluth, S | 1 |
Bremnes, RM; Brydøy, M; Fosså, SD; Gundersen, POM; Haugnes, HS; Hellesnes, R; Hjelle, LV; Oldenburg, J; Sprauten, M; Tandstad, T; Wilsgaard, T | 1 |
Brooks, B; Carleton, B; Clemens, E; de Vries, ACH; van den Heuvel-Eibrink, MM; van Grotel, M | 1 |
Chai, R; Guo, J; Li, H; Sun, S | 1 |
Castanheira, I; Ciarimboli, G; Karst, U; Köppen, C; Reifschneider, O; Sperling, M | 1 |
Bunne, M; Fosså, SD; Gundersen, POM; Osnes, T; Skalleberg, J; Småstuen, MC; Solheim, O | 1 |
Klis, SF; Sepmeijer, JW | 1 |
Allman, BL; Ding, D; Salvi, R | 1 |
Lautermann, J; McLaren, J; Schacht, J; Song, B | 1 |
4 review(s) available for platinum and Hearing Loss
Article | Year |
---|---|
Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum | 2022 |
The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review.
Topics: Adult; Antineoplastic Agents; Cancer Survivors; Carboplatin; Child; Cisplatin; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum; Quality of Life; Tinnitus | 2023 |
Protection of Hair Cells from Ototoxic Drug-Induced Hearing Loss.
Topics: Aminoglycosides; Antineoplastic Agents; Diuretics; Hair Cells, Auditory; Hearing Loss; Humans; Platinum | 2019 |
Review: ototoxic characteristics of platinum antitumor drugs.
Topics: Animals; Antineoplastic Agents; Cochlea; Hair Cells, Auditory; Hearing Loss; Humans; Platinum | 2012 |
12 other study(ies) available for platinum and Hearing Loss
Article | Year |
---|---|
Incidence of childhood hearing loss after in utero exposure to platinum agents.
Topics: Antineoplastic Agents; Child; Cohort Studies; Drug Therapy; Environmental Exposure; Female; Hearing Loss; Humans; Incidence; Infant; Infant, Newborn; Platinum; Pregnancy | 2021 |
Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity.
Topics: Antineoplastic Agents; Carboplatin; Child; Cisplatin; Follow-Up Studies; Hearing Loss; Humans; Ototoxicity; Platinum; Platinum Compounds | 2022 |
Severity of hearing loss after platinum chemotherapy in childhood cancer survivors.
Topics: Antineoplastic Agents; Cancer Survivors; Carboplatin; Child; Cisplatin; Hearing Loss; Humans; Neoplasms; Platinum | 2022 |
Cancer survivors and neurotoxic chemotherapy: hearing loss and tinnitus.
Topics: Cancer Survivors; Hearing Loss; Humans; Neoplasms; Nutrition Surveys; Platinum; Taxoids; Tinnitus; United States | 2023 |
Platinum-induced ototoxicity in pediatric cancer survivors: GSTP1 c.313A>G variant association.
Topics: Cancer Survivors; Carboplatin; Child; Cisplatin; Cross-Sectional Studies; Deafness; Glutathione S-Transferase pi; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum | 2022 |
Long term platinum-induced ototoxicity in pediatric patients.
Topics: Adolescent; Antineoplastic Agents; Audiometry; Child; Child, Preschool; Cohort Studies; Disease Progression; Female; Hearing Loss; Humans; Incidence; Infant; Male; Neoplasms; Platinum; Prospective Studies; Surveys and Questionnaires | 2018 |
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cancer Survivors; Cisplatin; Hearing Loss; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Platinum; Testicular Neoplasms; Young Adult | 2018 |
A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy.
Topics: Antineoplastic Agents; Audiometry; Carboplatin; Child; Cisplatin; Female; Hearing Loss; Humans; Male; Neoplasms; Platinum | 2019 |
Quantitative imaging of platinum based on laser ablation-inductively coupled plasma-mass spectrometry to investigate toxic side effects of cisplatin.
Topics: Animals; Cisplatin; Cochlea; Hearing Loss; Infertility, Male; Male; Mass Spectrometry; Mice; Molecular Imaging; Platinum; Testis | 2015 |
Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Audiometry, Pure-Tone; Bleomycin; Case-Control Studies; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Hearing Loss; Humans; Longitudinal Studies; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovariectomy; Platinum; Vinblastine; Young Adult | 2017 |
Distribution of platinum in blood and perilymph in relation to cisplatin induced ototoxicity in the guinea pig.
Topics: Action Potentials; Animals; Antineoplastic Agents; Auditory Threshold; Cisplatin; Cochlea; Dose-Response Relationship, Drug; Electrodes; Guinea Pigs; Hearing Loss; Male; Models, Animal; Perilymph; Platinum | 2009 |
Diet is a risk factor in cisplatin ototoxicity.
Topics: Animals; Antineoplastic Agents; Blood Urea Nitrogen; Cisplatin; Cochlea; Creatinine; Dietary Proteins; Glutathione; Guinea Pigs; Hearing Loss; Injections, Subcutaneous; Male; Platinum; Serum Albumin; Weight Gain | 1995 |